KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xenon Pharmaceuticals (XENE) Non Operating Investment Income: 2020-2021

Historic Non Operating Investment Income for Xenon Pharmaceuticals (XENE) over the last 2 years, with Dec 2021 value amounting to -$719,000.

  • Xenon Pharmaceuticals' Non Operating Investment Income fell 7476.47% to -$1.3 million in Q2 2022 from the same period last year, while for Jun 2022 it was -$4.7 million, marking a year-over-year change of. This contributed to the annual value of -$719,000 for FY2021, which is 18075.00% down from last year.
  • As of FY2021, Xenon Pharmaceuticals' Non Operating Investment Income stood at -$719,000, which was down 18,075.00% from $4,000 recorded in FY2020.
  • Xenon Pharmaceuticals' 5-year Non Operating Investment Income high stood at $4,000 for FY2020, and its period low was -$719,000 during FY2021.
  • In the last 2 years, Xenon Pharmaceuticals' Non Operating Investment Income had a median value of -$357,500 in 2020 and averaged -$357,500.
  • Data for Xenon Pharmaceuticals' Non Operating Investment Income shows a maximum YoY plummeted of 18,075.00% (in 2021) over the last 5 years.
  • Yearly analysis of 2 years shows Xenon Pharmaceuticals' Non Operating Investment Income stood at $4,000 in 2020, then plummeted by 18,075.00% to -$719,000 in 2021.